Romidepsin in the treatment of T-cell lymphoma: profile report (Q37952288)

25 August 2017

title

Romidepsin in the treatment of T-cell lymphoma: profile report (English)

1 reference

25 August 2017

Lily P H Yang

1 reference

25 August 2017

publication date

1 December 2011

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

393-395

1 reference

Update on the World Health Organization classification of peripheral T-cell lymphomas

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Management of advanced-stage peripheral T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

T-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Current and emerging treatment strategies for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Histone deacetylase inhibitors: current status and overview of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Epigenetic modifiers: basic understanding and clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Chemical phylogenetics of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Romidepsin: in the treatment of T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11207660-000000000-00000

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.47.301

Identifiers

DOI

10.2165/11207660-000000000-00000

1 reference

Dimensions Publication ID

25 August 2017

1027288821

0 references

1 reference